Dr. Ryan M O'Connell's lab focuses on understanding how gut cells and the immune system work together to maintain digestive health and prevent diseases like inflammatory bowel disease (IBD). The team investigates how tiny signaling particles called exosomes carry messages between cells in the gut, and how these messages can promote healing and fight inflammation. By exploring the roles of various molecules, including microRNAs and proteins in the communication between gut cells and bacteria, the lab aims to develop new therapies for inflammatory diseases.

At A. Brantley Hall's lab at the University of Maryland, researchers are focusing on understanding how gut bacteria produce hydrogen sulfide, a gas linked to health issues like colorectal cancer and ulcerative colitis. They are developing a unique device, called Smart Underwear, that can non-invasively measure this gas in real-time from human flatus. This innovative technology aims to provide insights into gut health and facilitate personalized dietary recommendations to improve overall well-being.

Dr. Karen Sandell Sfanos and her lab focus on understanding how gut bacteria produce androgen hormones that can affect cancer treatment effectiveness, particularly in metastatic prostate cancer. They explore the role of the microbiome in shaping how patients respond to immunotherapies and hormone therapies. Their goal is to identify bacterial genes and metabolites that contribute to resistance against cancer treatments, with the hope of finding new therapeutic approaches.

Dr. Gautam Dantas's lab at Washington University focuses on understanding how bacteria and viruses interact with the human gut microbiome, particularly in the context of infections like Clostridioides difficile. Their research aims to explore how early life factors, like antibiotic use, shape gut health and disease in children. By studying these microbial dynamics, the lab hopes to develop new approaches to prevent and treat microbiome-related diseases.

Dr. Zheng Kuang's lab at Carnegie-Mellon University focuses on understanding how gut microbiota influence the body's circadian rhythms and immune functions, particularly in relation to metabolism. The lab explores the interplay between our diet, gut microorganisms, and our internal biological clocks, investigating how these interactions can contribute to diseases in the digestive system. By using a variety of scientific techniques, the goal is to uncover new strategies to improve health by manipulating gut microbiota or epigenetic pathways.

Dr. Wenke Feng's lab at Tulane University focuses on understanding how gut-derived substances, especially from probiotics, influence liver health in the context of alcohol-associated liver diseases. The research explores the role of specific molecules in regulating bile acid and lipid synthesis, aiming to find new therapeutic strategies for better managing liver diseases associated with alcohol consumption.

Dr. Steven Zvi Josefowicz's lab focuses on understanding how a specific histone protein, H3.3, influences the immune system's response to infection and inflammation. They study how varying levels of H3.3 can adjust the activity of genes involved in immune functions, particularly in cells like macrophages and B cells. By exploring these mechanisms, the lab aims to uncover fundamental insights into how immune responses can be finely tuned, which has implications for treating various diseases.

Dr. James E. Haber's lab focuses on how cells sense and repair DNA damage, particularly double-strand breaks, using budding yeast as a model organism. They investigate the mechanisms involved in gene conversion and how this applies to both cancer biology and the Lyme disease bacterium. By utilizing advanced techniques, the lab aims to uncover the intricacies of DNA repair and its impact on genetic stability in both normal and diseased cells.

Dr. Hans Haecker's lab focuses on understanding how specific proteins and signaling pathways contribute to inflammatory diseases, particularly systemic lupus erythematosus (SLE). By investigating the roles of proteins in the Toll-like receptor (TLR) signaling pathway, the lab aims to uncover the mechanisms that lead to inappropriate immune responses. This research not only enhances our understanding of SLE but may also identify potential targets for new therapies.

Dr. Ya-Chieh Hsu's research lab at Harvard University focuses on understanding how stem cells age, particularly hair follicle stem cells (HFSCs). The lab studies the loss of regenerative capacity in aging stem cells and seeks to identify genes that could rejuvenate these cells. By employing advanced genetic techniques and innovative methods, the team aims to uncover the cellular changes that occur as HFSCs age, with hopes of developing therapies to combat age-related declines in stem cell function.

Dr. Rui Yi's lab at Northwestern University focuses on understanding how hair follicle stem cells function and age. The lab investigates the mechanical properties and the genetic regulation of these stem cells, exploring how they respond to their surrounding environment. By using advanced imaging and genetic tools, the research aims to uncover new insights into hair growth and potential treatments for age-related hair loss.

Dr. Jeffrey Scott Hale's lab focuses on understanding how CD4+ T cells respond to influenza infections. The research explores the mechanisms by which prior exposures to antigens, either through vaccination or infection, shape T cell responses in the lungs. By investigating T cell receptor signaling and epigenetic programming, the lab aims to improve vaccination strategies against influenza, potentially leading to longer-lasting immune protection.

Dr. Jeffrey D. Hardin's lab at the University of Wisconsin-Madison focuses on understanding how cells shape and move during the early stages of embryonic development, particularly in the model organism, C. elegans. The lab investigates the interaction of various proteins that support cell adhesion and movement, which can shed light on issues like birth defects and cancer mechanistically. By studying how cells rearrange themselves and maintain their structural integrity, this research aims to uncover important biological processes relevant to human health.

Dr. Laura C Harrington's lab at Cornell University focuses on understanding mosquito reproductive biology, particularly the Aedes aegypti species, which is a major vector for diseases like dengue, Zika, and chikungunya. The lab investigates specific molecules in male mosquito seminal fluid that affect female behavior and reproductive success, aiming to develop innovative mosquito control methods that target these molecules to decrease disease transmission. By unraveling the complexities of mosquito mating and reproduction, the lab is contributing to the fight against mosquito-borne illnesses.

Dr. Christopher D. Harvey's lab at Harvard Medical School focuses on understanding how the brain processes spatial navigation and decision-making, critical functions that can be impaired in diseases like Alzheimer's. The lab investigates the posterior parietal cortex (PPC), a brain region involved in these processes, by exploring its connectivity, the roles of different neuron types, and how these elements change during learning. This research aims to provide insights into the neuronal mechanisms that underpin cognitive functions and their disruptions in neurodegenerative conditions.

Dr. Peter Havel's research lab focuses on understanding how metabolic disorders like insulin resistance and type-2 diabetes can increase the risk of developing Alzheimer's disease and related dementias. Using a nonhuman primate model, the lab studies the impact of a high-sugar diet on brain health, particularly examining hormones, inflammation, and neural circuits involved in memory and behavior. The goal is to uncover mechanisms that link metabolic dysfunction and neurodegeneration to inform better treatments for these interconnected health issues.

Dr. Congcong He's lab at Northwestern University focuses on understanding how specific cellular processes influence cocaine addiction. The team investigates the role of autophagy, a recycling mechanism in cells, particularly how a protein called Becn2 interacts with dopamine receptors related to cocaine reward and relapse. By exploring these molecular pathways, the lab aims to identify potential new treatments for cocaine abuse and other drug addictions.

Dr. Elizabeth Head's research focuses on Alzheimer's disease and how to potentially slow its progression using specific medications. Her lab studies the effects of a drug called tacrolimus in aging beagle dogs, which can show signs of cognitive decline similar to humans. By measuring cognitive outcomes, biological markers, and brain health, the goal is to understand if targeting a specific pathway in the brain can serve as a new treatment strategy for Alzheimer's in humans.

Dr. Ellen Kraig's lab focuses on researching how certain drugs, called mTOR inhibitors, can promote healthier aging in older adults. The lab conducts studies to understand how different doses and schedules of these drugs affect the health and biology of elderly individuals. Through careful testing, they aim to determine the safest and most effective ways to use these drugs to improve health outcomes as people age.

Dr. Jiandong Liu's lab at the University of North Carolina Chapel Hill focuses on understanding the cellular dynamics and molecular mechanisms involved in heart regeneration and disease. The lab investigates how different types of cells in the heart, including macrophages and fibroblasts, contribute to heart function and tissue repair. Their research aims to uncover new therapeutic strategies for treating heart diseases by exploring how these cells interact and influence heart cell maturation.